Lockerman Financial Group’s Novo Nordisk NVO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$418K	Buy	+6,056	New	+$418K	0.56%	53
2024 Q2	–	Sell	-2,468	Closed	-$317K	–	111
2024 Q1	$317K	Buy	+2,468	New	+$317K	0.61%	50